127.42
1.09 (0.86%)
| Previous Close | 126.33 |
| Open | 128.20 |
| Volume | 125,988 |
| Avg. Volume (3M) | 318,039 |
| Market Cap | 4,583,399,424 |
| Price / Earnings (TTM) | 65.34 |
| Price / Sales | 4.64 |
| Price / Book | 5.71 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | 7.42% |
| Operating Margin (TTM) | 12.84% |
| Diluted EPS (TTM) | 1.94 |
| Quarterly Revenue Growth (YOY) | 1.10% |
| Quarterly Earnings Growth (YOY) | 44.50% |
| Total Debt/Equity (MRQ) | 57.49% |
| Current Ratio (MRQ) | 2.56 |
| Operating Cash Flow (TTM) | 157.37 M |
| Levered Free Cash Flow (TTM) | 152.43 M |
| Return on Assets (TTM) | 5.75% |
| Return on Equity (TTM) | 9.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (US) | Bearish | Mixed |
| Scientific & Technical Instruments (Global) | Bearish | Mixed | |
| Stock | Novanta Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -0.38 |
|
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Growth |
| % Held by Insiders | 0.86% |
| % Held by Institutions | 103.17% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Jun 2025 | Announcement | Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025 |
| 15 May 2025 | Announcement | Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025 |
| 13 May 2025 | Announcement | Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025 |
| 06 May 2025 | Announcement | Novanta Announces Financial Results for the First Quarter 2025 |
| 08 Apr 2025 | Announcement | Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |